|

Azacitidine in Combination With Venetoclax Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2: 1

Top Sponsors

  • First Affiliated Hospital of Zhejiang University1

Indications

  • Stem Cell Transplant Complications1
  • Hematologic Malignancy1
  • Cancer1

Other1 trial

Azacitidine in Combination With Venetoclax Treatment for MRD Positive Post Allo-HSCT AML/MDS Patients
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.